SII Tetanus Antitoxin Vaccine 1500 Tanzānija - angļu - Tanzania Medicinces & Medical Devices Authority

sii tetanus antitoxin vaccine 1500

serum institute of india pvt. ltd. (siipl), india - tetanus antitoxin - vaccine - 1500

TETANUS ANTITOXIN 1500 IU/ML BP 1500 IU/ML PARENTERAL ORDINARY VIALS Uganda - angļu - National Drug Authority

tetanus antitoxin 1500 iu/ml bp 1500 iu/ml parenteral ordinary vials

biological e. limited - tetanus antitoxin - parenteral ordinary vials - 1500 iu/ml

Antistax Capsules Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

antistax capsules

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - vitis vinifera -

ANTISTAX film coated tablets Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

antistax film coated tablets

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - vitis vinifera -

ANTITOX 2 FORMULA a.k.a. Huang Lian Jie Du Tang Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

antitox 2 formula a.k.a. huang lian jie du tang

sun herbal pty ltd - gardenia jasminoides, quantity: 85.8 mg (equivalent: gardenia jasminoides, qty 514.8 mg); scutellaria baicalensis, quantity: 85.8 mg (equivalent: scutellaria baicalensis, qty 514.8 mg); phellodendron amurense, quantity: 85.8 mg (equivalent: phellodendron amurense, qty 514.8 mg); coptis chinensis, quantity: 42.6 mg (equivalent: coptis chinensis, qty 255.6 mg) - capsule, hard - excipient ingredients: carrageenan; soluble maize starch; sodium citrate dihydrate; agar; hypromellose - traditionally used in chinese medicine to dispel/expel/disperse/clear fire ; traditionally used in chinese medicine to remove heat toxin

NORTHERN SERUMS CANINE PARALYSIS TICK ANTISERUM Austrālija - angļu - APVMA (Australian Pesticides and Veterinary Medicines Authority)

northern serums canine paralysis tick antiserum

northern serums pty ltd - antitoxin; mixed isomers of cresol - misc. vaccines or anti sera - antitoxin miscellaneous active 500.0 units/ml; mixed isomers of cresol phenol other 0.0017 ml/ml - immunotherapy - calf | cat | dog | horse foal | pigs | sheep | beef calf | bitch | boar | bovine | calf - poddy | calf - preweaning | calf - suc - paralysis tick | australian paralysis tick | scrub tick

TETANUS ANTITOXIN BEHRING Īrija - angļu - HPRA (Health Products Regulatory Authority)

tetanus antitoxin behring

intervet ireland limited - equine serum protein - solution for injection - unknown - clostridium antiserum qi05am01 clostridium antiserum qi07am antisera, immunoglobulin preparations, and antitoxins - canine, equine - food, ovine - immunological - antiserum

Tetanus Antitoxin Behring Īrija - angļu - HPRA (Health Products Regulatory Authority)

tetanus antitoxin behring

intervet ireland limited - equine serum protein - solution for injection - . - clostridium antiserum; clostridium antiserum; antisera, immunoglobulin preparations, and antitoxins - dogs, horses, sheep - immunological- antiserum

BAT- botulism antitoxin heptavalent liquid Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

bat- botulism antitoxin heptavalent liquid

emergent biosolutions canada inc. - equine botulinum neurotoxin a immune fab2 (unii: le3j6i6dxp) (equine botulinum neurotoxin a immune fab2 - unii:le3j6i6dxp), equine botulinum neurotoxin b immune fab2 (unii: vsk09vp4hl) (equine botulinum neurotoxin b immune fab2 - unii:vsk09vp4hl), equine botulinum neurotoxin c immune fab2 (unii: x5i2p7e9ty) (equine botulinum neurotoxin c immune fab2 - unii:x5i2p7e9ty), equine botulinum neurotoxin d immune fab2 (unii: 30y9n0sebe) (equine botulinum neurotoxin d immune fab2 - unii:30y9n0sebe), equine botul - equine botulinum neurotoxin a immune fab2 4500 [iu] in 10 ml - bat [botulism antitoxin heptavalent (a, b, c, d, e, f, g) – (equine)] is a mixture of immune globulin fragments indicated for the treatment of symptomatic botulism following documented or suspected exposure to botulinum neurotoxin serotypes a, b, c, d, e, f, or g in adults and pediatric patients. the effectiveness of bat is based on efficacy studies conducted in animal models of botulism. none. risk summary there are no human or animal data to establish the presence or absence of bat associated risk. risk summary there are no data to assess the presence or absence of bat in human milk, the effects on the breastfed child or the effects on milk production/excretion. consider the developmental and health benefits of breastfeeding along with the mother’s clinical need for bat and any potential adverse effects on the breastfed child from bat or from the underlying maternal condition. the effectiveness of bat has not been established in pediatric patients. limited pediatric safety data are available. fifteen pediat